KLF4 functions as an activator of the androgen receptor through reciprocal feedback

M-K Siu, F Suau, W-Y Chen, Y-C Tsai, H-Y Tsai, H-L Yeh, Y-N Liu

Research output: Contribution to journalArticle

Abstract

In prostate cancer, Krüppel-like factor 4 (KLF4) depletion occurs frequently, suggesting a role as suppressor tumor. KLF4 is a transcription factor associated with androgen receptor (AR) expression; however, its cellular functions and signaling regulation mechanism remain largely unknown. In this study, we demonstrated that activated AR binds to the KLF4 promoter and enhances KLF4 expression, which reciprocally targets the AR promoter, thus sustaining KLF4 activity. Ectopic KLF4 expression in androgen-independent prostate cancer cells induced AR expression and decreased cell proliferation, invasion and bone metastasis. We previously showed that increased microRNA (miR)-1 expression is associated with reduced bone metastasis of prostate cancer cells. Here we observed that KLF4 targets the primary miR-1-2 stem-loop promoter and stimulates miR-1 expression. In clinical prostate cancer specimens, KLF4 levels were positively correlated with miR-1 and AR levels. These data suggest that the loss of KLF4 expression is one mechanistic link between aggressive prostate cancer progression and low canonical AR output through miR-1 inactivation.
Original languageEnglish
Pages (from-to)e282
JournalOncogenesis
Volume5
Issue number12
DOIs
Publication statusPublished - Dec 2016

Fingerprint

Activator Appliances
Androgen Receptors
MicroRNAs
Prostatic Neoplasms
Neoplasm Metastasis
Bone and Bones
Androgens
Transcription Factors
Cell Proliferation

Cite this

KLF4 functions as an activator of the androgen receptor through reciprocal feedback. / Siu, M-K; Suau, F; Chen, W-Y; Tsai, Y-C; Tsai, H-Y; Yeh, H-L; Liu, Y-N.

In: Oncogenesis, Vol. 5, No. 12, 12.2016, p. e282.

Research output: Contribution to journalArticle

@article{1712740cb5574052b030d73f24380310,
title = "KLF4 functions as an activator of the androgen receptor through reciprocal feedback",
abstract = "In prostate cancer, Kr{\"u}ppel-like factor 4 (KLF4) depletion occurs frequently, suggesting a role as suppressor tumor. KLF4 is a transcription factor associated with androgen receptor (AR) expression; however, its cellular functions and signaling regulation mechanism remain largely unknown. In this study, we demonstrated that activated AR binds to the KLF4 promoter and enhances KLF4 expression, which reciprocally targets the AR promoter, thus sustaining KLF4 activity. Ectopic KLF4 expression in androgen-independent prostate cancer cells induced AR expression and decreased cell proliferation, invasion and bone metastasis. We previously showed that increased microRNA (miR)-1 expression is associated with reduced bone metastasis of prostate cancer cells. Here we observed that KLF4 targets the primary miR-1-2 stem-loop promoter and stimulates miR-1 expression. In clinical prostate cancer specimens, KLF4 levels were positively correlated with miR-1 and AR levels. These data suggest that the loss of KLF4 expression is one mechanistic link between aggressive prostate cancer progression and low canonical AR output through miR-1 inactivation.",
author = "M-K Siu and F Suau and W-Y Chen and Y-C Tsai and H-Y Tsai and H-L Yeh and Y-N Liu",
year = "2016",
month = "12",
doi = "10.1038/oncsis.2016.79",
language = "English",
volume = "5",
pages = "e282",
journal = "Oncogenesis",
issn = "2157-9024",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - KLF4 functions as an activator of the androgen receptor through reciprocal feedback

AU - Siu, M-K

AU - Suau, F

AU - Chen, W-Y

AU - Tsai, Y-C

AU - Tsai, H-Y

AU - Yeh, H-L

AU - Liu, Y-N

PY - 2016/12

Y1 - 2016/12

N2 - In prostate cancer, Krüppel-like factor 4 (KLF4) depletion occurs frequently, suggesting a role as suppressor tumor. KLF4 is a transcription factor associated with androgen receptor (AR) expression; however, its cellular functions and signaling regulation mechanism remain largely unknown. In this study, we demonstrated that activated AR binds to the KLF4 promoter and enhances KLF4 expression, which reciprocally targets the AR promoter, thus sustaining KLF4 activity. Ectopic KLF4 expression in androgen-independent prostate cancer cells induced AR expression and decreased cell proliferation, invasion and bone metastasis. We previously showed that increased microRNA (miR)-1 expression is associated with reduced bone metastasis of prostate cancer cells. Here we observed that KLF4 targets the primary miR-1-2 stem-loop promoter and stimulates miR-1 expression. In clinical prostate cancer specimens, KLF4 levels were positively correlated with miR-1 and AR levels. These data suggest that the loss of KLF4 expression is one mechanistic link between aggressive prostate cancer progression and low canonical AR output through miR-1 inactivation.

AB - In prostate cancer, Krüppel-like factor 4 (KLF4) depletion occurs frequently, suggesting a role as suppressor tumor. KLF4 is a transcription factor associated with androgen receptor (AR) expression; however, its cellular functions and signaling regulation mechanism remain largely unknown. In this study, we demonstrated that activated AR binds to the KLF4 promoter and enhances KLF4 expression, which reciprocally targets the AR promoter, thus sustaining KLF4 activity. Ectopic KLF4 expression in androgen-independent prostate cancer cells induced AR expression and decreased cell proliferation, invasion and bone metastasis. We previously showed that increased microRNA (miR)-1 expression is associated with reduced bone metastasis of prostate cancer cells. Here we observed that KLF4 targets the primary miR-1-2 stem-loop promoter and stimulates miR-1 expression. In clinical prostate cancer specimens, KLF4 levels were positively correlated with miR-1 and AR levels. These data suggest that the loss of KLF4 expression is one mechanistic link between aggressive prostate cancer progression and low canonical AR output through miR-1 inactivation.

U2 - 10.1038/oncsis.2016.79

DO - 10.1038/oncsis.2016.79

M3 - Article

VL - 5

SP - e282

JO - Oncogenesis

JF - Oncogenesis

SN - 2157-9024

IS - 12

ER -